Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Small Cap Fund median (34 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Aug 2010 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty Smallcap 250 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | DSP Small Cap Fund |
|---|---|
| 03 Aug 2010 | ₹100.00 |
| 04 Dec 2011 | ₹83.95 |
| 06 Apr 2013 | ₹90.23 |
| 07 Aug 2014 | ₹171.76 |
| 09 Dec 2015 | ₹247.93 |
| 10 Apr 2017 | ₹352.72 |
| 12 Aug 2018 | ₹359.61 |
| 13 Dec 2019 | ₹275.61 |
| 14 Apr 2021 | ₹339.75 |
| 16 Aug 2022 | ₹422.97 |
| 17 Dec 2023 | ₹555.18 |
| 19 Apr 2025 | ₹508.57 |
| 20 Aug 2026 | ₹630.27 |
| Metric | DSP · Regular · IDCW NAV ₹63.42 Very High risk ★★☆☆☆ | Category median Small Cap Fund · 34 funds |
|---|---|---|
| +8.41% | +7.77% | |
| +8.96% | +11.04% | |
| +8.49% | +13.21% | |
| +7.60% | +11.26% | |
| +12.16% | +15.35% | |
| +9.43% | — | |
| +15.82% | +16.66% | |
| +14.77% | +15.71% | |
| +13.53% | +12.21% | |
| Risk | ||
| 19.26% | 18.02% | |
| 0.13 | 0.37 | |
| 0.16 | 0.48 | |
| -60.67% | -36.49% | |
| Nifty Smallcap 250 | — | |
| -6.75% | -1.99% | |
| 1.01 | 0.88 | |
| 88.2% | 83.6% | |
| 113.4% | 86.1% | |
| 1.69% | 2.00% | |
| ₹18,087Cr | ₹5,674Cr | |
| 1.00% | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 6% | 27% | |
| Vinit Sambre | — | |
| 03 Aug 2010 | — | |
| 80 | — | |
| 28.6% | — | |
| 11.3% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.